GB0606416D0 - Immunogenic composition - Google Patents

Immunogenic composition

Info

Publication number
GB0606416D0
GB0606416D0 GB0606416A GB0606416A GB0606416D0 GB 0606416 D0 GB0606416 D0 GB 0606416D0 GB 0606416 A GB0606416 A GB 0606416A GB 0606416 A GB0606416 A GB 0606416A GB 0606416 D0 GB0606416 D0 GB 0606416D0
Authority
GB
United Kingdom
Prior art keywords
immunogenic composition
immunogenic
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0606416A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline Biologicals SA
Original Assignee
GlaxoSmithKline Biologicals SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GlaxoSmithKline Biologicals SA filed Critical GlaxoSmithKline Biologicals SA
Priority to GB0606416A priority Critical patent/GB0606416D0/en
Publication of GB0606416D0 publication Critical patent/GB0606416D0/en
Priority to PE2007000353A priority patent/PE20080774A1/en
Priority to JOP/2007/0087A priority patent/JO3418B1/en
Priority to PE2011001600A priority patent/PE20120262A1/en
Priority to PE2007000349A priority patent/PE20080129A1/en
Priority to CL2007000839A priority patent/CL2007000839A1/en
Priority to ARP070101307A priority patent/AR060188A1/en
Priority to ARP070101306A priority patent/AR060187A1/en
Priority to TW096110815A priority patent/TWI494124B/en
Priority to JOP/2007/0092A priority patent/JO3420B1/en
Priority to EP07727531.1A priority patent/EP2019689B1/en
Priority to PCT/EP2007/053059 priority patent/WO2007113223A2/en
Priority to CA2647441A priority patent/CA2647441C/en
Priority to SG201101719-1A priority patent/SG170090A1/en
Priority to NZ595178A priority patent/NZ595178A/en
Priority to EP16192711.6A priority patent/EP3141261A1/en
Priority to CA2647450A priority patent/CA2647450C/en
Priority to UAA200810922A priority patent/UA97359C2/en
Priority to US12/294,643 priority patent/US8933218B2/en
Priority to JP2009502102A priority patent/JP5759671B2/en
Priority to BRPI0710210-0A priority patent/BRPI0710210A2/en
Priority to NZ570805A priority patent/NZ570805A/en
Priority to EP12164166A priority patent/EP2476434A1/en
Priority to EA200801839A priority patent/EA015833B1/en
Priority to AU2007233705A priority patent/AU2007233705B2/en
Priority to PCT/EP2007/053060 priority patent/WO2007113224A2/en
Priority to CNA2007800104140A priority patent/CN101410135A/en
Priority to MYPI20083840A priority patent/MY148405A/en
Priority to EP07727529A priority patent/EP1998802A2/en
Priority to EA201101164A priority patent/EA020459B1/en
Priority to EP07727532.9A priority patent/EP2026841B1/en
Priority to PCT/EP2007/053057 priority patent/WO2007113222A2/en
Priority to US12/294,689 priority patent/US8703148B2/en
Priority to JP2009502100A priority patent/JP2009531387A/en
Priority to EP20120164165 priority patent/EP2476433A1/en
Priority to MX2008012405A priority patent/MX337528B/en
Priority to KR1020087026511A priority patent/KR101541383B1/en
Priority to CN2013100995763A priority patent/CN103169960A/en
Priority to CA2647455A priority patent/CA2647455C/en
Priority to ES07727532.9T priority patent/ES2659050T3/en
Priority to ES07727531.1T priority patent/ES2659925T3/en
Priority to JP2009502101A priority patent/JP5491853B2/en
Priority to US12/294,774 priority patent/US20100021503A1/en
Priority to TW096111419A priority patent/TWI425951B/en
Priority to IL193565A priority patent/IL193565A/en
Priority to NO20083722A priority patent/NO20083722L/en
Priority to ZA2008/08246A priority patent/ZA200808246B/en
Priority to CR10348A priority patent/CR10348A/en
Priority to MA31304A priority patent/MA30343B1/en
Priority to AU2011201158A priority patent/AU2011201158B2/en
Priority to IL227934A priority patent/IL227934A/en
Priority to CR20150097A priority patent/CR20150097A/en
Priority to US15/840,527 priority patent/US20180104323A1/en
Ceased legal-status Critical Current

Links

GB0606416A 2006-03-30 2006-03-30 Immunogenic composition Ceased GB0606416D0 (en)

Priority Applications (53)

Application Number Priority Date Filing Date Title
GB0606416A GB0606416D0 (en) 2006-03-30 2006-03-30 Immunogenic composition
PE2007000353A PE20080774A1 (en) 2006-03-30 2007-03-28 IMMUNOGENIC COMPOSITION INCLUDING PNAG OF STAPHYLACCOCES CONJUGATED WITH A CARRIER PROTEIN AND CAPSULAR POLYSACCHARIDE OR OLIGOSACCHARIDE OF S. AUREUS
JOP/2007/0087A JO3418B1 (en) 2006-03-30 2007-03-28 Conjugation process for pnag and a carrier protein
PE2011001600A PE20120262A1 (en) 2006-03-30 2007-03-28 PROCEDURE FOR THE PREPARATION OF IMMUNOCONJUGATES INCLUDING POLYSACCHARIDE OR CAPSULAR OLIGOSACCHARIDE FROM S. AUREUS TOGETHER WITH THE CARRIER PROTEIN
PE2007000349A PE20080129A1 (en) 2006-03-30 2007-03-28 CONJUGATION PROCEDURE
CL2007000839A CL2007000839A1 (en) 2006-03-30 2007-03-28 Process for producing a conjugate comprising a polysaccharide or oligosaccharide of type 5 or 8 of s. aureus and a carrier protein; immunogenic conjugate comprising it; vaccine comprising the conjugate; procedure for obtaining said vaccine; and use of the conjugate to treat or prevent staph infection
ARP070101307A AR060188A1 (en) 2006-03-30 2007-03-28 CONJUGATION PROCEDURE
ARP070101306A AR060187A1 (en) 2006-03-30 2007-03-28 IMMUNOGENIC COMPOSITION
TW096110815A TWI494124B (en) 2006-03-30 2007-03-28 Immunogenic composition
JOP/2007/0092A JO3420B1 (en) 2006-03-30 2007-03-28 Pharmaceutical composition and vaccine against staphylococcal infections
EP07727531.1A EP2019689B1 (en) 2006-03-30 2007-03-29 Pharmaceutical composition and vaccine against staphylococcal infections
PCT/EP2007/053059 WO2007113223A2 (en) 2006-03-30 2007-03-29 Immunogenic composition
CA2647441A CA2647441C (en) 2006-03-30 2007-03-29 Immunogenic composition comprising staphylococcus aureus saccharides
SG201101719-1A SG170090A1 (en) 2006-03-30 2007-03-29 Immunogenic composition
NZ595178A NZ595178A (en) 2006-03-30 2007-03-29 Vaccine comprising Type 5 and Type 8 capsular polysaccharides from Staphyloccocus aureus
EP16192711.6A EP3141261A1 (en) 2006-03-30 2007-03-29 Immunogenic composition
CA2647450A CA2647450C (en) 2006-03-30 2007-03-29 Process for producing a staphylococcal conjugate
UAA200810922A UA97359C2 (en) 2006-03-30 2007-03-29 Immunogenic composition
US12/294,643 US8933218B2 (en) 2006-03-30 2007-03-29 Conjugation process for PNAG and a carrier protein
JP2009502102A JP5759671B2 (en) 2006-03-30 2007-03-29 Joining method
BRPI0710210-0A BRPI0710210A2 (en) 2006-03-30 2007-03-29 immunogenic composition, vaccine, methods for preparing the vaccine, and for preventing or treating staphylococcal infection, use of the immunogenic composition, and process for conjugating oligosaccharide or capsular polysaccharide
NZ570805A NZ570805A (en) 2006-03-30 2007-03-29 Vaccine comprising Type 5 and Type 8 capsular polysaccharides from Staphyloccocus aureus
EP12164166A EP2476434A1 (en) 2006-03-30 2007-03-29 Immunogenic composition
EA200801839A EA015833B1 (en) 2006-03-30 2007-03-29 Immunogenic composition
AU2007233705A AU2007233705B2 (en) 2006-03-30 2007-03-29 Immunogenic composition
PCT/EP2007/053060 WO2007113224A2 (en) 2006-03-30 2007-03-29 Conjugation process for pnag and a carrier protein
CNA2007800104140A CN101410135A (en) 2006-03-30 2007-03-29 Immunogenic composition
MYPI20083840A MY148405A (en) 2006-03-30 2007-03-29 Immunogenic composition
EP07727529A EP1998802A2 (en) 2006-03-30 2007-03-29 Immunogenic composition
EA201101164A EA020459B1 (en) 2006-03-30 2007-03-29 Immunogenic composition
EP07727532.9A EP2026841B1 (en) 2006-03-30 2007-03-29 Conjugation process for pnag and a carrier protein
PCT/EP2007/053057 WO2007113222A2 (en) 2006-03-30 2007-03-29 Immunogenic composition
US12/294,689 US8703148B2 (en) 2006-03-30 2007-03-29 Immunogenic composition
JP2009502100A JP2009531387A (en) 2006-03-30 2007-03-29 Immunogenic composition
EP20120164165 EP2476433A1 (en) 2006-03-30 2007-03-29 Immunogenic composition
MX2008012405A MX337528B (en) 2006-03-30 2007-03-29 Immunogenic composition.
KR1020087026511A KR101541383B1 (en) 2006-03-30 2007-03-29 immunogenic composition
CN2013100995763A CN103169960A (en) 2006-03-30 2007-03-29 Immunogenic composition
CA2647455A CA2647455C (en) 2006-03-30 2007-03-29 Processes for the conjugation of poly n-acetylated glucosamine to a carrier protein
ES07727532.9T ES2659050T3 (en) 2006-03-30 2007-03-29 Conjugation procedure for PNAG and a transporter protein
ES07727531.1T ES2659925T3 (en) 2006-03-30 2007-03-29 Pharmaceutical composition and vaccine against staphylococcal infections
JP2009502101A JP5491853B2 (en) 2006-03-30 2007-03-29 Immunogenic composition
US12/294,774 US20100021503A1 (en) 2006-03-30 2007-03-29 Immunogenic composition
TW096111419A TWI425951B (en) 2006-03-30 2007-03-30 Conjugation process
IL193565A IL193565A (en) 2006-03-30 2008-08-20 Immunogenic composition comprising staphylococcus aureus type v and/or type viii capsular polysaccharide or oligosaccharide and vaccine comprising such for treatment of staphylococcal infection
NO20083722A NO20083722L (en) 2006-03-30 2008-08-29 Immunogenic composition
ZA2008/08246A ZA200808246B (en) 2006-03-30 2008-09-26 Immunogenic composition
CR10348A CR10348A (en) 2006-03-30 2008-10-07 IMMUNOGENIC COMPOSITION
MA31304A MA30343B1 (en) 2006-03-30 2008-10-17 IMMUNOGENIC COMPOSITION
AU2011201158A AU2011201158B2 (en) 2006-03-30 2011-03-16 Immunogenic composition
IL227934A IL227934A (en) 2006-03-30 2013-08-13 Immunogenic composition comprising type 5 and/or 8 capsular polysaccharide or oligosaccharide from s. aureus and various aspects related thereto
CR20150097A CR20150097A (en) 2006-03-30 2015-02-25 IMMUNOGENIC COMPOSITION
US15/840,527 US20180104323A1 (en) 2006-03-30 2017-12-13 Immunogenic composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0606416A GB0606416D0 (en) 2006-03-30 2006-03-30 Immunogenic composition

Publications (1)

Publication Number Publication Date
GB0606416D0 true GB0606416D0 (en) 2006-05-10

Family

ID=36424917

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0606416A Ceased GB0606416D0 (en) 2006-03-30 2006-03-30 Immunogenic composition

Country Status (3)

Country Link
CN (1) CN101410135A (en)
GB (1) GB0606416D0 (en)
UA (1) UA97359C2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI1015567A2 (en) * 2009-06-22 2021-08-31 Wyeth Llc IMMUNOGENIC COMPOSITIONS OF ANTIGENS FROM STAPHYLOCOCCUS AUREUS
SG10201406432RA (en) * 2009-06-22 2014-11-27 Wyeth Llc Compositions and methods for preparing staphylococcus aureus serotype 5 and 8 capsular polysaccharide conjugate immunogenic compositions
DK2654784T3 (en) * 2010-12-22 2017-02-13 Wyeth Llc STABLE IMMUNOGENIC COMPOSITIONS OF STAPHYLOCOCCUS AUREUS ANTIGENES
GB201310008D0 (en) * 2013-06-05 2013-07-17 Glaxosmithkline Biolog Sa Immunogenic composition for use in therapy
MX370488B (en) * 2013-12-04 2019-12-16 Glaxosmithkline Biologicals Sa Prevention of staphylococcus aureus infections by glycoprotein vaccines synthesized in escherichia coli.

Also Published As

Publication number Publication date
CN101410135A (en) 2009-04-15
UA97359C2 (en) 2012-02-10

Similar Documents

Publication Publication Date Title
HUS2200002I1 (en) Immunogenic composition
IL227934A0 (en) Immunogenic composition
GB0526038D0 (en) Immunogenic composition
EP2018182A4 (en) Immunogenic compositions
GB0606416D0 (en) Immunogenic composition
ZA200710909B (en) Immunogenic composition
GB0606856D0 (en) Vaccine compositions
ZA200710854B (en) Immunogenic composition
GB0606417D0 (en) Immunogenic composition
GB0714158D0 (en) Immunogenic composition
GB0602761D0 (en) Vaccine Composition
GB0524204D0 (en) Immunogenic composition
GB0503143D0 (en) Immunogenic composition
GB0515556D0 (en) Immunogenic composition
GB0526040D0 (en) Immunogenic composition
GB0526041D0 (en) Immunogenic composition
GB0602185D0 (en) Composition
GB0600902D0 (en) Composition

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)